A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate

Novartis

Status and phase: Completed; Phase 3

Conditions: Osteoporosis

Treatments: Drug: zoledronic acid

Study type: Interventional

Funder types: Industry

Identifiers

NCT00100555

CZOL446H2315

Details and patient eligibility

About

The purpose of this trial is to study the clinical safety, tolerability, and efficacy of zoledronic acid compared to an oral bisphosphonate in postmenopausal women with osteoporosis.

Sex: Female

Ages: 45 to 79 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Postmenopausal women between 45 and 79 years of age
• Must be osteopenic/osteoporotic

Exclusion criteria

• Any women of child-bearing potential

Other protocol-defined inclusion/exclusion criteria may apply.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind